Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parkinsonism. Multiple system atrophy

G K Wenning1, N P Quinn

  • 1Universitätsklinik für Neurologie, Innsbruck, Austria.

Bailliere'S Clinical Neurology
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Signs of early cellular dysfunction in multiple system atrophy.

Neuropathology and applied neurobiology·2020
Same author

Development of neurodegeneration in amyotrophic lateral sclerosis: from up or down?

Journal of neural transmission (Vienna, Austria : 1996)·2020
Same author

Key themes and future prospects in translational multiple system atrophy research.

Autonomic neuroscience : basic & clinical·2017
Same author

Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.

Parkinsonism & related disorders·2016
Same author

Review: Multiple system atrophy: emerging targets for interventional therapies.

Neuropathology and applied neurobiology·2016
Same author

Interventional trials in atypical parkinsonism.

Parkinsonism & related disorders·2015

Multiple system atrophy (MSA) is a distinct neurological disorder. Early diagnosis is challenging but crucial for effective patient management and clinical trials, requiring advanced diagnostic tools and further research into its pathogenesis and treatments.

Area of Science:

  • Neurology
  • Pathology
  • Neuroscience

Background:

  • Multiple system atrophy (MSA) is now recognized as a distinct clinicopathological entity.
  • Historically, confusion arose from overlapping pathology with striatonigral degeneration (SND), sporadic olivopontocerebellar atrophy (OPCA), and Shy-Drager syndrome (SDS).
  • The identification of glial and neuronal inclusions confirms these as manifestations of the same disease.

Purpose of the Study:

  • To highlight the diagnostic challenges in early Multiple System Atrophy (MSA) cases, particularly those presenting with parkinsonism.
  • To discuss the utility of various diagnostic tools in differentiating MSA from idiopathic Parkinson's disease (IPD).
  • To emphasize the urgent need for improved therapeutic strategies and further research into MSA pathogenesis.

Main Methods:

Related Experiment Videos

  • Review of clinical features associated with MSA, including parkinsonism and autonomic failure.
  • Discussion of neuroimaging techniques such as MRI, MRS, PET, and SPECT.
  • Mention of autonomic function tests and external sphincter EMG for differential diagnosis.

Main Results:

  • Parkinsonism is the most common motor disorder in MSA.
  • Diagnostic difficulty is pronounced in early stages, especially with isolated parkinsonism.
  • Certain clinical signs and diagnostic tests can aid in differentiating MSA from IPD.

Conclusions:

  • Accurate early diagnosis of MSA is critical for patient care and clinical trials.
  • Current medical treatments for MSA are often disappointing, underscoring the need for better therapies.
  • Further research into MSA pathogenesis, including glial cytoplasmic inclusions (GCIs), and development of novel treatments, such as grafting techniques, are essential.